Pilot Injection of Microscale Zerovalent Iron for Aquifer Remediation

Background/Objectives. Concentrated suspensions of microscale and nanoscale zerovalent iron particles (MZVI and NZVI) have been studied in recent years for the remediation of contaminated aquifers. In the framework of the research project AQUAREHAB (FP7 - G. A. Nr. 226565), a pilot injection test of guar gum stabilized microsized zerovalent iron has been designed and performed under low pressure in a CAHs contaminated site in Belgium and the resulting radius of influence was determined. Approach/Activities. A shear thinning guar gum solution (2 g/l) was selected as an environmentally friendly stabilizer of the iron particles. The relevant properties of the iron slurry (iron particles size and concentration, polymeric stabilizer type and concentration, slurry viscosity) were designed in the laboratory based on several tests (namely iron reactivity tests towards contaminants, sedimentation tests and rheological measurements). Since the injection regime of iron slurries depends on subsurface geotechnical parameters, aquifer hydraulic conductivity, and fluid properties, a specific injection well and monitoring strategy have been developed in order to achieve high discharge rates and radii of influence, and a more homogeneous distribution of the iron particles through low pressure injection. The injection well has been designed and sealed in order to sustain average to high discharge rates, preventing the daylighting of the product. Moreover the well has been hydraulically tested by means of innovative water and guar gum step rate tests in order to determine the most suitable injection rate for the iron slurry. The injection of 50 kg of microsized iron particles (BASF, Germany), dispersed in 5 m3 of a 2 g/l guar gum suspension, was performed at a discharge rate of 1.5 m3/h. The monitoring of the process has been conducted measuring injection rate and pressure as well as iron concentration by means of a magnetic susceptometer. After the injection, the iron distribution in the subsurface was determined through liners extraction and the iron concentration measured both via non-invasive magnetic susceptibility measurements and chemical analysis. Results/Lessons Learned. Even if the field test was specifically designed to inject in a permeation regime, or on the threshold between permeation and fracturing, the results of monitoring injection pressure and iron distribution proved that particles migration in the porous medium occurred via preferential flow. Nevertheless significant radius of influence was achieved during the pilot test

Are Commercial EV Chargers Ready to Aid with Household Power Consumption?

The transportation industry now accounts for approximately a quarter of worldwide energy-related direct CO2 emissions, and governments all around the globe have committed to converting their fossil-fuel vehicles to zero-emission ones by adopting electric vehicles. Current electric vehicles (EV) can store approximately 18 to 100 kWh of energy, which may be employed not only for commuting but also for other purposes such as delivering energy to households (V2H) or buildings (V2B), as well as offering ancillary services to the power grid (V2G). In this study, a real test setting including a trending bidirectional charger, an EV, a PV simulator, and household appliances are utilized to evaluate the performance of various V2H components and to learn about the concerns that may arise during V2H operation. The results of the tests on the bidirectional EV charger are presented in this paper. Although the results of the tests on the charger installed in the house are not satisfactory and consistent to the project’s goal, they are released in order to aid future studies in better understanding the true challenges of commercial bidirectional chargers

TAS2R38 is a novel modifer gene in patients with cystic fbrosis

The clinical manifestation of cystic fbrosis (CF) is heterogeneous also in patients with the same cystic fbrosis transmembrane regulator (CFTR) genotype and in afected sibling pairs. Other genes, inherited independently of CFTR, may modulate the clinical manifestation and complications of patients with CF, including the severity of chronic sinonasal disease and the occurrence of chronic Pseudomonas aeruginosa colonization. The T2R38 gene encodes a taste receptor and recently its functionality was related to the occurrence of sinonasal diseases and upper respiratory infections. We assessed the T2R38 genotype in 210 patients with CF and in 95 controls, relating the genotype to the severity of sinonasal disease and to the occurrence of P. aeruginosa pulmonary colonization. The frequency of the PAV allele i.e., the allele associated with the high functionality of the T2R38 protein, was signifcantly lower in i) CF patients with nasal polyposis requiring surgery, especially in patients who developed the complication before 14 years of age; and ii) in CF patients with chronic pulmonary colonization by P. aeruginosa, especially in patients who were colonized before 14 years of age, than in control subjects. These data suggest a role for T2R38 as a novel modifer gene of sinonasal disease severity and of pulmonary P. aeruginosa colonization in patients with CF

A Creatine Transporter Is Operative at the Brush Border Level of the Rat Jejunal Enterocyte

Abstract Although ergogenic effects and health benefits have been reported for creatine used as nutritional supplement, to date little is known about the mechanism of creatine absorption in the small intestine. Thus the current study was undertaken to elucidate the mechanism of creatine intake in rat jejunum with the use of well-purified brush border membrane vesicles, isolated from jejunal enterocyte. Creatine uptake was found markedly stimulated by inwardly directed Na(+) and Cl(- )gradients, potential-sensitive, strongly reduced by the substitution of Na(+) and Cl(-) with various cations and anions and positively affected by intravesicular K(+). Moreover, creatine uptake is: 1) significantly inhibited by creatine structural analogs, 2) abolished by low concentrations of 2-aminoethyl methanethiosulfonate hydrobromide (MTSEA), 3) saturable as a function of creatine concentration with an apparent Michaelis-Menten constant of 24.08 +/- 0.80 muM and a maximal velocity of 391.30 +/- 6.19 pmoles mg protein(-1) 30 s(-1). The transport is electrogenic since at least two Na(+) and one Cl(-) are required to transport one creatine molecule. Western blot analysis showed the same amount of creatine transport protein in the jejunal apical membrane when compared to ileum. Thus, these data demonstrate the existence of a Na(+)- and Cl(-)-dependent, membrane potential-sensitive, electrogenic carrier-mediated mechanism for creatine absorption in rat jejunal apical membrane vesicles, which is biochemically and pharmacologically similar to those observed in other tissues. However, in other cell types the stimulatory effect of intravesicular K(+) was never detected

Alginate nanohydrogels as a biocompatible platform for the controlled release of a hydrophilic herbicide

The large-scale application of volatile and highly water-soluble pesticides to guarantee crop production can often have negative impacts on the environment. The main loss pathways are vapor drift, direct volatilization, or leaching of the active substances. Consequently, the pesticide can either accumulate and/or undergo physicochemical transformations in the soil. In this scenario, we synthesized alginate nanoparticles using an inverse miniemulsion template in sunflower oil and successfully used them to encapsulate a hydrophilic herbicide, i.e., dicamba. The formulation and process conditions were adjusted to obtain a unimodal size distribution of nanohydrogels of about 20 nm. The loading of the nanoparticles with dicamba did not affect the nanohydrogel size nor the particle stability. The release of dicamba from the nanohydrogels was also tested: the alginate nanoparticles promoted the sustained and prolonged release of dicamba over ten days, demonstrating the potential of our preparation method to be employed for field application. The encapsulation of hydrophilic compounds inside our alginate nanoparticles could enable a more efficient use of pesticides, minimizing losses and thus environmental spreading. The use of biocompatible materials (alginate, sunflower oil) also guarantees the absence of toxic additives in the formulation

Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors

Pancreatic cancer (PC) is one of the most aggressive cancers in the world. Several extracellular factors are involved in its development and metastasis to distant organs. In PC, the protein Annexin A1 (ANXA1) appears to be overexpressed and may be identified as an oncogenic factor, also because it is a component in tumor-deriving extracellular vesicles (EVs). Indeed, these microvesicles are known to nourish the tumor microenvironment. Once we evaluated the autocrine role of ANXA1-containing EVs on PC MIA PaCa-2 cells and their pro-angiogenic action, we investigated the ANXA1 paracrine effect on stromal cells like fibroblasts and endothelial ones. Concerning the analysis of fibroblasts, cell migration/invasion, cytoskeleton remodeling, and the different expression of specific protein markers, all features of the cell switching into myofibroblasts, were assessed after administration of wild type more than ANXA1 Knock-Out EVs. Interestingly, we demonstrated a mechanism by which the ANXA1-EVs complex can stimulate the activation of formyl peptide receptors (FPRs), triggering mesenchymal switches and cell motility on both fibroblasts and endothelial cells. Therefore, we highlighted the importance of ANXA1/EVs-FPR axes in PC progression as a vehicle of intercommunication tumor cells-stroma, suggesting a specific potential prognostic/diagnostic role of ANXA1, whether in soluble form or even if EVs are captured in PC

Elección de la tiroidectomía subtotal en el tratamiento del Basedow

For the present study, 768 hipertiroideous patients at Córdoba Hospital has been evaluated since 1977 to 1985. Medical treatment has been applied to 503 patients that represents 66 %. A second group of 201 patients, that represents 26 %, has received surgical treatment, and a third group of 64 patients, representing 8,3 %, received treatment. Each treatment complications has been evaluated to suggest subtotal tiroidectomy as choosen treatment in basedow

High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells

: Melanoma cells express high levels of CD73 that produce extracellular immunosuppressive adenosine. Changes in the CD73 expression occur in response to tumor environmental factors, contributing to tumor phenotype plasticity and therapeutic resistance. Previously, we have observed that CD73 expression can be up-regulated on the surface of melanoma cells in response to nutritional stress. Here, we explore the mechanism by which melanoma cells release soluble CD73 under low nutrient availability and whether this might be affected by agents targeting the proto-oncogene B-Raf (BRAF). We found that starved melanoma cells can release high levels of CD73, able to convert AMP into adenosine, and this activity is abrogated by selective CD73 inhibitors, APCP or PSB-12489. The release of CD73 from melanoma cells is mediated by the matrix metalloproteinase MMP-9. Indeed, MMP-9 inhibitors significantly reduce the levels of CD73 released from the cells, while its surface levels increase. Of relevance, melanoma cells, harboring an activating BRAF mutation, upon treatment with dabrafenib or vemurafenib, show a strong reduction of CD73 cell expression and reduced levels of CD73 released into the extracellular space. Conversely, melanoma cells resistant to dabrafenib show high expression of membrane-bound CD73 and soluble CD73 released into the culture medium. In summary, our data indicate that CD73 is released from melanoma cells. The expression of CD73 is associated with response to BRAF inhibitors. Melanoma cells developing resistance to dabrafenib show increased expression of CD73, including soluble CD73 released from cells, suggesting that CD73 is involved in acquiring resistance to treatment